ShanghaiBio Corporation, a maker of diagnostic tools that is getting into the CRO business, said it expects to make its IPO sometime during the next year. ShanghaiBio, also known as Shanghai Biochip, claims to be one of the largest biotech companies in China. SBC started by making biochips. In fact, the company is the National Engineering Center for biochip design and engineering in Shanghai. Now, SBC is branching out into the CRO business, primarily in the pre-clinical area, and revenues for this division, though still small, are on the upswing. More details... 

Stock Symbol: (NYSE: WX)